FrançaisMovember
Movember
For more information visit
www.movember.com

In The News

Prostate Cancer Awareness Day at BC Legislative Assembly
VICTORIA, May 4, 2012- On Monday, May 7, Prostate Cancer Canada (PCC) will host their first Legislative Assembly Day to promote education and awareness of prostate cancer in British Columbia.

Media Advisory - Prostate Cancer Canada celebrates local Halifax hero
HALIFAX, April 25, 2012 /CNW/ - Please join Prostate Cancer Canada and members of the Halifax business community as we celebrate a local hero who has made an extraordinary contribution in the fight against prostate cancer through courage, inspiration and dedication.

Click For Information Archive
Print this page.  Bookmark this page. Decrease font size.Increase font size.


In Search of a New Prostate Cancer Biomarker

Dr. Jeremy Squire (2003 and 2005 Research Grants)

Prostatic Intraepithelial Neoplasia (PIN) is a non cancerous prostate condition but it has the potential to turn into cancer. High grade PIN, in particular, is a significant risk factor for prostate cancer. Dr. Squire’s research focuses on the links between high grade PIN and prostate cancer and he has found a promising new biomarker that may help diagnose the cases of PIN that are most likely to turn into prostate cancer. This biomarker is called a telomere. Telomeres are structures found on the ends of chromosomes that protect chromosomes from mutations and play an important role in deciding the number of times a cell can divide.

Every time an older cell divides it loses a tiny piece of DNA from the telomere. This process is called telomere attrition and it can make the telomeres too short to work properly, which causes the chromosomes to rearrange and result in genetic mutations (which in turn lead to high grade PIN and prostate cancer).

Squire’s study looked at a group of 68 men with high grade PIN (but not prostate cancer) and compared the lengths of their telomeres. The study found several significant links between short telomere length and long term diagnosis of prostate cancer – suggesting that telomere attrition in PIN is the basis of genetic mutations that cause prostate cancer.

In collaboration with local nanotechnology experts, Dr. Squire is now looking for quick and cost effective ways to measure telomere length during biopsies.
Join us June 17th for the Father's Day Walk/Run! It's a great way to support the men in your life. http://t.co/xBbU1C7t #FDWR
Follow Us On Twitter
Prostate Cancer Canada
2 Lombard Street, 3rd Floor, Toronto
Ontario M5C 1M1, Canada
info@prostatecancer.ca

Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325

Please note we cannot provide medical advice or endorse specific services, products, treatments or medical centres.
© 2011 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development Inorbital